Autophagy controls BCG-induced trained immunity and the response to intravesical BCG therapy for bladder cancer
Kathrin Buffen, Marije Oosting, Jessica Quintin, Aylwin Ng, Johanneke Kleinnijenhuis, Vinod Kumar, Esther van de Vosse, Cisca Wijmenga, Reinout van Crevel, Egbert Oosterwijk, Anne J Grotenhuis, Sita H Vermeulen, Lambertus A Kiemeney, Frank L van de Veerdonk, Georgios Chamilos, Ramnik J Xavier, Jos W M van der Meer, Mihai G Netea, Leo A B Joosten, Kathrin Buffen, Marije Oosting, Jessica Quintin, Aylwin Ng, Johanneke Kleinnijenhuis, Vinod Kumar, Esther van de Vosse, Cisca Wijmenga, Reinout van Crevel, Egbert Oosterwijk, Anne J Grotenhuis, Sita H Vermeulen, Lambertus A Kiemeney, Frank L van de Veerdonk, Georgios Chamilos, Ramnik J Xavier, Jos W M van der Meer, Mihai G Netea, Leo A B Joosten
Abstract
The anti-tuberculosis-vaccine Bacillus Calmette-Guérin (BCG) is the most widely used vaccine in the world. In addition to its effects against tuberculosis, BCG vaccination also induces non-specific beneficial effects against certain forms of malignancy and against infections with unrelated pathogens. It has been recently proposed that the non-specific effects of BCG are mediated through epigenetic reprogramming of monocytes, a process called trained immunity. In the present study we demonstrate that autophagy contributes to trained immunity induced by BCG. Pharmacologic inhibition of autophagy blocked trained immunity induced in vitro by stimuli such as β-glucans or BCG. Single nucleotide polymorphisms (SNPs) in the autophagy genes ATG2B (rs3759601) and ATG5 (rs2245214) influenced both the in vitro and in vivo training effect of BCG upon restimulation with unrelated bacterial or fungal stimuli. Furthermore, pharmacologic or genetic inhibition of autophagy blocked epigenetic reprogramming of monocytes at the level of H3K4 trimethylation. Finally, we demonstrate that rs3759601 in ATG2B correlates with progression and recurrence of bladder cancer after BCG intravesical instillation therapy. These findings identify a key role of autophagy for the nonspecific protective effects of BCG.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
- Durrant WE, Dong X (2004) Systemic acquired resistance. Annu Rev Phytopathol 42: 185–209.
- Pham LN, Dionne MS, Shirasu-Hiza M, Schneider DS (2007) A specific primed immune response in Drosophila is dependent on phagocytes. PLoS Pathog 3: e26.
- Sun JC, Beilke JN, Lanier LL (2009) Adaptive immune features of natural killer cells. Nature 457: 557–561.
- O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH (2006) T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 7: 507–516.
- Netea MG, Quintin J, van der Meer JW (2011) Trained immunity: a memory for innate host defense. Cell Host Microbe 9: 355–361.
- Quintin J, Saeed S, Martens JH, Giamarellos-Bourboulis EJ, Ifrim DC, et al. (2012) Candida albicans infection affords protection against reinfection via functional reprogramming of monocytes. Cell Host Microbe 12: 223–232.
- Kleinnijenhuis J, Quintin J, Preijers F, Joosten LA, Ifrim DC, et al. (2012) Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 109: 17537–17542.
- Husnjak K, Dikic I (2012) Ubiquitin-binding proteins: decoders of ubiquitin-mediated cellular functions. Annu Rev Biochem 81: 291–322.
- Jagannath C, Lindsey DR, Dhandayuthapani S, Xu Y, Hunter RL Jr, et al. (2009) Autophagy enhances the efficacy of BCG vaccine by increasing peptide presentation in mouse dendritic cells. Nat Med 15: 267–276.
- Min Y, Xu W, Liu D, Shen S, Lu Y, et al. (2010) Autophagy promotes BCG-induced maturation of human dendritic cells. Acta Biochim Biophys Sin (Shanghai) 42: 177–182.
- Velikkakath AK, Nishimura T, Oita E, Ishihara N, Mizushima N (2012) Mammalian Atg2 proteins are essential for autophagosome formation and important for regulation of size and distribution of lipid droplets. Mol Biol Cell 23: 896–909.
- Kawai K, Miyazaki J, Joraku A, Nishiyama H, Akaza H (2013) Bacillus Calmette-Guerin (BCG) immunotherapy for bladder cancer: current understanding and perspectives on engineered BCG vaccine. Cancer Sci 104: 22–27.
- Foster SL, Hargreaves DC, Medzhitov R (2007) Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 447: 972–978.
- Trunz BB, Fine P, Dye C (2006) Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 367: 1173–1180.
- Levine MI, Sackett MF (1946) Results of BCG immunization in New York City. Am Rev Tuberc 53: 517–532.
- Aronson JD (1948) Protective vaccination against tuberculosis, with special reference to BCG vaccine. Minn Med 31: 1336.
- Ferguson RG, Simes AB (1949) BCG vaccination of Indian infants in Saskatchewan. Tubercle 30: 5–11.
- Velema JP, Alihonou EM, Gandaho T, Hounye FH (1991) Childhood mortality among users and non-users of primary health care in a rural west African community. Int J Epidemiol 20: 474–479.
- Niobey FM, Duchiade MP, Vasconcelos AG, de Carvalho ML, Leal Mdo C, et al. (1992) [Risk factors for death caused by pneumonia in children younger than 1 year old in a metropolitan region of southeastern Brazil. A case- control study]. Rev Saude Publica 26: 229–238.
- Kristensen I, Aaby P, Jensen H (2000) Routine vaccinations and child survival: follow up study in Guinea-Bissau, West Africa. BMJ 321: 1435–1438.
- Garly ML, Martins CL, Bale C, Balde MA, Hedegaard KL, et al. (2003) BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa. A non-specific beneficial effect of BCG? Vaccine 21: 2782–2790.
- Vaugelade J, Pinchinat S, Guiella G, Elguero E, Simondon F (2004) Non-specific effects of vaccination on child survival: prospective cohort study in Burkina Faso. BMJ 329: 1309.
- Aaby P, Roth A, Ravn H, Napirna BM, Rodrigues A, et al. (2011) Randomized trial of BCG vaccination at birth to low-birth-weight children: beneficial nonspecific effects in the neonatal period? J Infect Dis 204: 245–252.
- Biering-Sorensen S, Aaby P, Napirna BM, Roth A, Ravn H, et al. (2012) Small randomized trial among low-birth-weight children receiving bacillus Calmette-Guerin vaccination at first health center contact. Pediatr Infect Dis J 31: 306–308.
- Hersh EM, Gutterman JU, Mavligit GM (1977) BCG as adjuvant immunotherapy for neoplasia. Annu Rev Med 28: 489–515.
- Ifrim DC, Quintin J, Joosten LA, Jacobs C, Jansen T, et al. (2014) Trained immunity or tolerance: opposing functional programs induced in human monocytes after engagement of various pattern recognition receptors. Clin Vaccine Immunol 21: 534–545.
- Rafnar T, Vermeulen SH, Sulem P, Thorleifsson G, Aben KK, et al. (2011) European genome-wide association study identifies SLC14A1 as a new urinary bladder cancer susceptibility gene. Hum Mol Genet 20: 4268–4281.
- Songane M, Kleinnijenhuis J, Alisjahbana B, Sahiratmadja E, Parwati I, et al. (2012) Polymorphisms in autophagy genes and susceptibility to tuberculosis. PLoS One 7: e41618.
- Smeekens SP, Ng A, Kumar V, Johnson MD, Plantinga TS, et al. (2013) Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat Commun 4: 1342.
Source: PubMed